Company Overview
| Stock Name | 錦欣生殖醫療集團有限公司 |
|---|---|
| Stock Code | 01951 |
| Company Full Name | 錦欣生殖醫療集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 公司主要在中國及美國提供輔助生殖服務、管理服務及輔助醫療服務。 |
| Listing Date | 2019-06-25 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國四川省成都市錦江區靜沙北路301號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.jxr-fertility.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.54 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 38.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,219,956,080 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 9.28 |
|---|---|
| First Day Open | HK$ 9.9 |
| First Day Change | 8.67% |
| First Day Volume | 228624000.0 |
| First Day Turnover | 2239680000.0 |
Use of Proceeds
| Use of Proceeds | 1、約25.0%或702.0百萬港元將用于拓展及升級我們中國網絡的現有輔助生殖醫療機構及招聘醫療專業人士； 2、約20.0%或561.6百萬港元將用于我們目前并無經營的中國省份的額外輔助生殖醫療機構潛在收購； 3、約10.0%或280.8百萬港元將用于投資研發以改善整體表現及維持我們ART的前沿地位； 4、約20.0%或561.6百萬港元將用于輔助生殖服務服務鏈的輔助生殖服務提供商及業務潛在收購； 5、約15.0%或421.2百萬港元將用于改善品牌專注度以及中國及美國對輔助生殖服務的整體專注； 6、約10.0%或280.8百萬港元將用于營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
中信证券（香港）有限公司 CE AAK249
Overall Coordinators (4)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
花旗环球金融亚洲有限公司 CE AAA137
招商证券（香港）有限公司 CE AAI650
Joint Bookrunners (10)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
花旗环球金融亚洲有限公司 CE AAA137
招商证券（香港）有限公司 CE AAI650
招银国际融资有限公司 CE AVM940
中信建投（国际）融资有限公司 CE BAU112
农银国际融资有限公司 CE AWL249
工银国际融资有限公司 CE AQW615
华泰金融控股（香港）有限公司 CE AOK809
Mirae Asset Securities (HK) Limited CE BJB333
Joint Lead Managers (10)
摩根士丹利亚洲有限公司 CE AAD291
中信里昂证券有限公司 CE AAB893
花旗环球金融亚洲有限公司 CE AAA137
招商证券（香港）有限公司 CE AAI650
招银国际融资有限公司 CE AVM940
中信建投（国际）融资有限公司 CE BAU112
农银国际融资有限公司 CE AWL249
工银国际融资有限公司 CE AQW615
华泰金融控股（香港）有限公司 CE AOK809
Mirae Asset Securities (HK) Limited CE BJB333
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Ally Bridge LB Healthcare Master Fund Limited | 235,174,520 HKD | — | 7.71% | — | 6 months | 2019-12-25 |
| 2 | Cormorant Asset Management, LP | 156,777,320 HKD | — | 5.14% | — | 6 months | 2019-12-25 |
| 3 | Hillhouse Funds | 548,746,240 HKD | — | 17.99% | — | 6 months | 2019-12-25 |
| 4 | Worldwide Healthcare Trust PLC | 235,174,520 HKD | — | 7.71% | — | 6 months | 2019-12-25 |
Directors & Management
| Chairman | 鐘勇 |
|---|---|
| Company Secretary | 鐘曼娜 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | JINXIN Fertility Investment Group Limited(12.77%);HRC Investment Cayman LLC(11.87%);HHLR Advisors, Ltd.(7.47%) |
|---|
